Saffron Walden, United Kingdom

Naimisha Trivedi

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 6.3

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Naimisha Trivedi: Innovator in Respiratory Therapeutics

Introduction

Naimisha Trivedi is a notable inventor based in Saffron Walden, GB. With a total of six patents to his name, he has made significant contributions to the field of respiratory therapeutics. His work focuses on developing innovative compounds that target specific enzymes and receptors involved in respiratory diseases.

Latest Patents

Trivedi's latest patents include aminoester derivatives that serve as both phosphodiesterase 4 (PDE4) enzyme inhibitors and muscarinic M3 receptor antagonists. These compounds are designed to be useful in the prevention and treatment of diseases of the respiratory tract. Specifically, they address conditions characterized by airway obstruction, showcasing his commitment to improving respiratory health.

Career Highlights

Throughout his career, Naimisha Trivedi has worked with prominent companies in the pharmaceutical industry, including Chiesi Farmaceutici S.p.a. and Merck Sharp & Dohme B.v. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research in respiratory therapeutics.

Collaborations

Trivedi has collaborated with esteemed colleagues such as Elisabetta Armani and Gabriele Amari. These partnerships have further enhanced his research and development efforts, leading to innovative solutions in the field.

Conclusion

Naimisha Trivedi's work exemplifies the impact of innovation in the pharmaceutical industry, particularly in the realm of respiratory health. His patents and collaborations reflect a dedication to advancing therapeutic options for patients suffering from respiratory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…